What is the current valuation of the US mitral valve-stenosis market?

The market valuation was $668.47 Million in 2024. Read More

What is the projected market size for the US mitral valve-stenosis market by 2035?

The projected valuation for 2035 is $1678.84 Million. Read More

What is the expected CAGR for the US mitral valve-stenosis market during the forecast period?

The expected CAGR for the market from 2025 - 2035 is 8.73%. Read More

Which companies are the key players in the US mitral valve-stenosis market?

Key players include Abbott Laboratories, Medtronic, Boston Scientific, Edwards Lifesciences, LivaNova, JenaValve Technology, Cardiac Dimensions, and AtriCure. Read More

What are the main segments of the US mitral valve-stenosis market?

The main segments include Diagnostic Tests, Treatment, Medication, Procedures, and End Users. Read More

What was the valuation of the Diagnostic Tests segment in 2024?

The Diagnostic Tests segment had a valuation ranging from $50.0 Million to $400.0 Million. Read More

What is the projected valuation for the Treatment segment by 2035?

The Treatment segment is projected to reach a valuation between $468.47 Million and $1178.84 Million by 2035. Read More

What are the key components of the Medication segment in the US mitral valve-stenosis market?

Key components include Diuretics, Blood Thinners, Beta Blockers, Anti-Arrhythmic Drugs, and Antibiotics. Read More

What is the expected growth for the Mitral Valve Replacement procedure segment?

The Mitral Valve Replacement procedure segment is projected to grow to a valuation between $218.47 Million and $528.84 Million by 2035. Read More

Which end users dominate the US mitral valve-stenosis market?

The dominant end users include Hospitals & Clinics, Diagnostic Centers, and other healthcare facilities. Read More

US Mitral Valve Stenosis Market

ID: MRFR/MED/13965-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

United States Mitral Valve Stenosis Market Research Report: Size, Share, Trend Analysis - Growth & Industry Forecast 2025 To 2035

English

US Mitral Valve Stenosis Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Diagnostic Test (USD Million)
  1. 4.1.1 Electrocardiogram (ECG)
  2. 4.1.2 Transthoracic Echocardiogram
  3. 4.1.3 Transesophageal Echocardiogram
  4. 4.1.4 Cardiac Catheterization
  5. 4.1.5 Others
2. 4.2 Healthcare, BY Treatment (USD Million)
  1. 4.2.1 Medication
  2. 4.2.2 Procedures
3. 4.3 Healthcare, BY Medication (USD Million)
  1. 4.3.1 Diuretics
  2. 4.3.2 Blood Thinners
  3. 4.3.3 Beta Blockers
  4. 4.3.4 Anti-Arrhythmic Drugs
  5. 4.3.5 Antibiotics
4. 4.4 Healthcare, BY Procedures (USD Million)
  1. 4.4.1 Mitral Valvuloplasty
  2. 4.4.2 Mitral Valve Surgery
  3. 4.4.3 Mitral Valve Repair
  4. 4.4.4 Mitral Valve Replacement
5. 4.5 Healthcare, BY End User (USD Million)
  1. 4.5.1 Hospital & Clinics
  2. 4.5.2 Diagnostic Centers
  3. 4.5.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott Laboratories (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Medtronic (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Boston Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Edwards Lifesciences (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 LivaNova (GB)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 JenaValve Technology (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Cardiac Dimensions (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 AtriCure (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY DIAGNOSTIC TEST
3. 6.3 US MARKET ANALYSIS BY TREATMENT
4. 6.4 US MARKET ANALYSIS BY MEDICATION
5. 6.5 US MARKET ANALYSIS BY PROCEDURES
6. 6.6 US MARKET ANALYSIS BY END USER
7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF HEALTHCARE
10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
13. 6.13 HEALTHCARE, BY DIAGNOSTIC TEST, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY DIAGNOSTIC TEST, 2024 TO 2035 (USD Million)
15. 6.15 HEALTHCARE, BY TREATMENT, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY TREATMENT, 2024 TO 2035 (USD Million)
17. 6.17 HEALTHCARE, BY MEDICATION, 2024 (% SHARE)
18. 6.18 HEALTHCARE, BY MEDICATION, 2024 TO 2035 (USD Million)
19. 6.19 HEALTHCARE, BY PROCEDURES, 2024 (% SHARE)
20. 6.20 HEALTHCARE, BY PROCEDURES, 2024 TO 2035 (USD Million)
21. 6.21 HEALTHCARE, BY END USER, 2024 (% SHARE)
22. 6.22 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY DIAGNOSTIC TEST, 2025-2035 (USD Million)
  2. 7.2.2 BY TREATMENT, 2025-2035 (USD Million)
  3. 7.2.3 BY MEDICATION, 2025-2035 (USD Million)
  4. 7.2.4 BY PROCEDURES, 2025-2035 (USD Million)
  5. 7.2.5 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Healthcare Market Segmentation

Healthcare By Diagnostic Test (USD Million, 2025-2035)

Electrocardiogram (ECG)
Transthoracic Echocardiogram
Transesophageal Echocardiogram
Cardiac Catheterization
Others

Healthcare By Treatment (USD Million, 2025-2035)

Medication
Procedures

Healthcare By Medication (USD Million, 2025-2035)

Diuretics
Blood Thinners
Beta Blockers
Anti-Arrhythmic Drugs
Antibiotics

Healthcare By Procedures (USD Million, 2025-2035)

Mitral Valvuloplasty
Mitral Valve Surgery
Mitral Valve Repair
Mitral Valve Replacement

Healthcare By End User (USD Million, 2025-2035)

Hospital & Clinics
Diagnostic Centers
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”